Multiple hypothetical pathways have been discussed previously, and Chen, C.H., et al. showed in leukemia cells [17] the activation of MAPKs and caspases, the upregulation of p53, Bax, Fas, and Fas-L expression and GSH depletion. This evidence concerns the gene TP53 and leukemia.